Loading clinical trials...
Loading clinical trials...
A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-week Treatment Switched to Tazorac® Cream, 0.1% 6-week Treatment in Patients With Acne Vulgaris
Conditions
Interventions
Adapalene Gel, 0.1%
Tazarotene Cream, 0.1%
+1 more
Locations
12
United States
Therapeutics Clinical Research
San Diego, California, United States
Henry Ford Medical Center-Dept. of Dermatology
Detroit, Michigan, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
State University of New York Downstate Medical Center-Dept. of Dermatology
Brooklyn, New York, United States
Dermatology Research Associates
Cincinnati, Ohio, United States
Phoebe Rich, MD & Associates
Portland, Oregon, United States
Start Date
February 1, 2006
Primary Completion Date
September 1, 2006
Completion Date
September 1, 2006
Last Updated
July 29, 2022
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions